Log in to save to my catalogue

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ccf35cb7b13416ab15c68f68cc441cf

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

About this item

Full title

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

Publisher

Basel: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2022-09, Vol.12 (9), p.1239

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Cancer is a genetic mutation disease that seriously endangers the health and life of all human beings. As one of the most amazing academic achievements in the past decade, CRISPR/Cas9 technology has been sought after by many researchers due to its powerful gene editing capability. CRISPR/Cas9 technology shows great potential in oncology, and has be...

Alternative Titles

Full title

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2ccf35cb7b13416ab15c68f68cc441cf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ccf35cb7b13416ab15c68f68cc441cf

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom12091239

How to access this item